1613625-68-5

Upstream product

• 1336154-46-1 C₁₄H₁₉NO₃ 
• 77260-03-8 methyl β-(8-methoxy-1,2,3,4-tetrahydro-5-naphthyl)-propionate 
• 1008-19-1 5-methoxy-1,2,3,4-tetrahydro-naphthalene 
• 529-35-1 5,6,7,8-Tetrahydronaphthalen-1-ol 
• 1613625-66-3 C₁₉H₂₇NO₅ 
• 1613626-58-6 C₁₄H₁₉NO₃*ClH 
• 1613625-65-2 C₁₃H₁₇NO₃*BrH 
• 1613625-64-1 C₁₄H₁₉NO₃*C₂H₄O₂ 
• 1613625-63-0 C₁₄H₁₇N₃O₃ 
• 1613625-62-9 C₂₄H₂₆N₄O₄ 
• 1613625-61-8 C₂₄H₂₇NO₄ 
• 70179-57-6 β-(8-methoxy-1,2,3,4-tetrahydro-5-naphthyl)-propionic acid 
• 883531-98-4 4-methoxy-5,6,7,8-tetrahydronaphthalene-1-carbaldehyde 
• 1613625-67-4 C₂₀H₂₆F₃NO₇S 

Downstream Products

• 1613625-69-6 C₃₀H₃₆N₂O₆ 
• 1613625-70-9 C₃₀H₃₇N₃O₅ 
• 1613625-72-1 C₃₀H₄₁N₃O₅ 
• 1613625-73-2 C₂₅H₃₃N₃O₃ 
• 1613625-74-3 C₃₃H₄₈N₄O₅ 
• 1613625-75-4 C₄₁H₅₄N₄O₇ 
• 1613625-76-5 C₃₆H₄₆N₄O₅ 

Relevant academic research and scientific papers

3,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS

The present invention relates compounds of the formula: or pharmaceutically acceptable salts thereof, useful as sodium channel blockers, as well as compositions containing the same, processes for the preparation of the same, and therapeutic methods of use therefore in promoting hydration of mucosal surfaces and the treatment of diseases including cystic fibrosis, chronic obstructive pulmonary disease, asthma, bronchiectasis, acute and chronic bronchitis, emphysema, and pneumonia.

3,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS

The present invention relates compounds of the formula: or pharmaceutically acceptable salts thereof, useful as sodium channel blockers, as well as compositions containing the same, processes for the preparation of the same, and therapeutic methods of use therefore in promoting hydration of mucosal surfaces and the treatment of diseases including cystic fibrosis, chronic obstructive pulmonary disease, asthma, bronchiectasis, acute and chronic bronchitis, emphysema, and pneumonia.

CHLORO-PYRAZINE CARBOXAMIDE DERIVATIVES WITH EPITHELIAL SODIUM CHANNEL BLOCKING ACTIVITY

This invention provides compounds of the formula I: and their pharmaceutically acceptable salts, useful as sodium channel blockers, compositions containing the same, therapeutic methods and uses for the same and processes for preparing the same.